CSI Market
Sign In | Register

Nrx Pharmaceuticals Inc (NRXP) Annual Balance Sheets

Annual · GAAP · USD millions
Access NRXP quarterly Balance Sheets →
This page allows investors to track Nrx Pharmaceuticals Inc's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent7.80
Cash & Short-term Investments7.00
Accounts receivable0.16
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.93
Total Current Assets8.89
Equipment/Property/Plant Net0.06
Goodwill net1.79
Intangible Assets0.93
Long-term investments0.40
Other Assets, Noncurrent1.28
Operating Lease Right Of Use Asset0.41
Total Assets12.96
Liabilities
Accounts Payable, Current AC4.27
Accrued Liabilities, Current AC0.00
Derivative Liability, Current DE12.30
Loans Payable, Current NO0.00
Other Liabilities, Current12.00
Business Combination, Contingent Consideration, Liability, Current BU0.00
Total Current Liabilities28.58
Convertible Notes Payable, Noncurrent LO0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.32
NotesPayableAndAccruedInterestNonCurrent-
Accrued Clinical Site Costs-
Contract With Customer Liability Current-
Notes Payable And Accrued Interest Current-
Accrued Liabilities And Other Current Liabilities11.34
Total Liabilities28.89
Stockholders' Equity
Common Stock Value0.03
Additional Paid In Capital Common Stock290.93
Retained Earnings / Accumulated Deficit-306.90
Other Equity0.00
Common Stockholder's Equity-15.94
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-15.94
Liabilities & Stockholder's Equity12.96
4 historic quarters locked

Sign in to unlock the full Nrx Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Nrx Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-009418

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.